Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene.
作者信息
Cooper-Knock Johnathan, Zhang Sai, Kenna Kevin P, Moll Tobias, Franklin John P, Allen Samantha, Nezhad Helia Ghahremani, Iacoangeli Alfredo, Yacovzada Nancy Y, Eitan Chen, Hornstein Eran, Elhaik Eran, Celadova Petra, Bose Daniel, Farhan Sali, Fishilevich Simon, Lancet Doron, Morrison Karen E, Shaw Christopher E, Al-Chalabi Ammar, Veldink Jan H, Kirby Janine, Snyder Michael P, Shaw Pamela J
出版信息
Cell Rep. 2021 Feb 2;34(5):108730. doi: 10.1016/j.celrep.2021.108730.
Abstract
摘要
相似文献
1
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene.增强子内的罕见变异负担分析确定CAV1为肌萎缩侧索硬化症风险基因。
Cell Rep. 2021 Feb 2;34(5):108730. doi: 10.1016/j.celrep.2021.108730.
2
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene.在增强子中进行罕见变异负担分析，确定 CAV1 为 ALS 风险基因。
Cell Rep. 2020 Dec 1;33(9):108456. doi: 10.1016/j.celrep.2020.108456.
3
Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival.对CAV1和CAV2的大规模分析表明，它们在ALS患者死后的脑组织中的表达较高，并影响生存期。
Front Cell Neurosci. 2023 Mar 2;17:1112405. doi: 10.3389/fncel.2023.1112405. eCollection 2023.
4
Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies as a candidate in PLS.罕见变异分析在多民族人群中验证了已知的肌萎缩侧索硬化症（ALS）相关基因，并确定了一个进行性延髓麻痹（PLS）的候选基因。
Res Sq. 2023 Dec 21:rs.3.rs-3721598. doi: 10.21203/rs.3.rs-3721598/v1.
5
Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies as a candidate in PLS.罕见变异分析在多民族人群中验证了已知的肌萎缩侧索硬化症（ALS）基因，并确定了其作为进行性延髓麻痹（PLS）的一个候选基因。
medRxiv. 2023 Oct 23:2023.09.30.23296353. doi: 10.1101/2023.09.30.23296353.
6
Rare variant analyses validate known ALS genes in a multi-ethnic population and identifies ANTXR2 as a candidate in PLS.罕见变异分析在多民族人群中验证了已知的 ALS 基因，并确定 ANTXR2 为 PLS 的候选基因。
BMC Genomics. 2024 Jun 29;25(1):651. doi: 10.1186/s12864-024-10538-1.
7
Whole Exome Sequencing Identifies a Heterozygous Variant in the Cav1.3 Gene Associated with Familial Sinus Node Dysfunction and Focal Idiopathic Epilepsy.全外显子组测序鉴定出与家族性窦房结功能障碍和局灶性特发性癫痫相关的 Cav1.3 基因杂合变异。
Int J Mol Sci. 2022 Nov 17;23(22):14215. doi: 10.3390/ijms232214215.
8
Burden of rare variants in ALS genes influences survival in familial and sporadic ALS.肌萎缩侧索硬化症（ALS）基因中罕见变异的负担影响家族性和散发性ALS的生存率。
Neurobiol Aging. 2017 Oct;58:238.e9-238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007. Epub 2017 Jun 20.
9
The evolving genetic risk for sporadic ALS.散发性肌萎缩侧索硬化不断变化的遗传风险。
Neurology. 2017 Jul 18;89(3):226-233. doi: 10.1212/WNL.0000000000004109. Epub 2017 Jun 22.
10
A CACNA1C variant associated with reduced voltage-dependent inactivation, increased CaV1.2 channel window current, and arrhythmogenesis.一种与电压依赖性失活降低、CaV1.2通道窗电流增加和心律失常发生相关的CACNA1C变体。
PLoS One. 2014 Sep 3;9(9):e106982. doi: 10.1371/journal.pone.0106982. eCollection 2014.
引用本文的文献
1
A systematic review and functional analysis of genes and variants associated with amyotrophic lateral sclerosis.与肌萎缩侧索硬化相关的基因和变异的系统综述与功能分析。
Front Neurosci. 2025 Jun 16;19:1598336. doi: 10.3389/fnins.2025.1598336. eCollection 2025.
2
Mutations in the tail and rod domains of the neurofilament heavy-chain gene increase the risk of ALS.神经丝重链基因尾部和杆状结构域的突变增加了 ALS 的发病风险。
Ann Clin Transl Neurol. 2024 Jul;11(7):1775-1786. doi: 10.1002/acn3.52083. Epub 2024 May 22.
3
Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data.无监督机器学习在死后运动皮层和血液表达数据中识别出不同的肌萎缩侧索硬化症分子亚型。
Acta Neuropathol Commun. 2023 Dec 21;11(1):208. doi: 10.1186/s40478-023-01686-8.
4
Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy.肌萎缩侧索硬化症遗传学的最新进展及基因治疗面临的挑战。
Front Neurosci. 2023 May 12;17:1170996. doi: 10.3389/fnins.2023.1170996. eCollection 2023.
5
Early Alterations in Structural and Functional Properties in the Neuromuscular Junctions of Mutant FUS Mice.突变 FUS 小鼠神经肌肉接头结构和功能特性的早期改变。
Int J Mol Sci. 2023 May 19;24(10):9022. doi: 10.3390/ijms24109022.
6
Subpial delivery of adeno-associated virus 9-synapsin-caveolin-1 () preserves motor neuron and neuromuscular junction morphology, motor function, delays disease onset, and extends survival in hSOD1 mice.腺相关病毒 9-突触素-窖蛋白-1()经软脑膜给药可维持运动神经元和神经肌肉接头形态、运动功能，延迟疾病发作，并延长 hSOD1 小鼠的生存期。
Theranostics. 2022 Jul 11;12(12):5389-5403. doi: 10.7150/thno.72614. eCollection 2022.
7
Neuronal-glial communication perturbations in murine SOD1 spinal cord.鼠 SOD1 脊髓中的神经元-胶质通讯障碍。
Commun Biol. 2022 Feb 28;5(1):177. doi: 10.1038/s42003-022-03128-y.
8
Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD.突触结合蛋白-小窝蛋白-1基因疗法可保留神经元和突触形态，并预防阿尔茨海默病小鼠模型中的神经退行性变。
Mol Ther Methods Clin Dev. 2021 Mar 29;21:434-450. doi: 10.1016/j.omtm.2021.03.021. eCollection 2021 Jun 11.
Zotero 插件